Mutant BCL11B in a Patient With a Neurodevelopmental Disorder and T-Cell Abnormalities
Authors:
Open Access
- 19 October 2020
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Pediatrics
- Vol. 8, 544894
Abstract
Background: BCL11B encodes B-cell lymphoma/leukemia 11B, a transcription factor that participates in the differentiation and migration of neurons and lymphocyte cells. De novo mutations of BCL11B have been associated with neurodevelopmental disorder and immunodeficiency, such as immunodeficiency 49 (IMD49) and intellectual developmental disorder with speech delay, dysmorphic facies, and T-cell abnormalities (IDDSFTA). However, the pathogenesis of the neurodevelopmental disorder and T-cell deficiency is still mysterious. The strategy to distinguish these two diseases in detail is also unclear. Methods: A patient with unique clinical features was identified. Multiple examinations were applied for evaluation. Whole-exome sequencing (WES) and Sanger sequencing were also performed for the identification of the disease-causing mutation. Results: We reported a 17-month-old girl with intellectual disability, speech impairment, and delay in motor development. She presented with mild dysmorphic facial features and weak functional movement. MRI indicated the abnormal myelination of the white matter. Immunological analysis showed normal levels of RTEs and γδT cells but a deficiency of naive T cells. Genetic sequencing identified a de novo heterozygous frameshift mutation c.1192_1196delAGCCC in BCL11B. Conclusions: An IDDSFTA patient of East Asian origin was reported. The unreported neurological display, immunophenotype, and a novel disease-causing mutation of the patient extended the spectrum of clinical features and genotypes of IDDSFTA.Keywords
This publication has 23 references indexed in Scilit:
- BCL11B mutations in patients affected by a neurodevelopmental disorder with reduced type 2 innate lymphoid cellsBrain, 2018
- Priming of lineage-specifying genes by Bcl11b is required for lineage choice in post-selection thymocytesNature Communications, 2017
- Bcl11b—A Critical Neurodevelopmental Transcription Factor—Roles in Health and DiseaseFrontiers in Cellular Neuroscience, 2017
- A Quiescent Bcl11b High Stem Cell Population Is Required for Maintenance of the Mammary GlandCell Stem Cell, 2017
- The transcription factor Bcl11b is specifically expressed in group 2 innate lymphoid cells and is essential for their developmentJournal of Experimental Medicine, 2015
- Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular PathologyGenetics in Medicine, 2015
- γδ T Lymphocytes in the Diagnosis of Human T Cell Receptor ImmunodeficienciesFrontiers in Immunology, 2015
- HIV gag-specific immune response mediated by double negative (CD3+CD4−CD8−) T cells in HIV-exposed seronegative individualsJournal of Medical Virology, 2012
- Ctip2/Bcl11b controls ameloblast formation during mammalian odontogenesisProceedings of the National Academy of Sciences, 2009
- BCL11B participates in the activation of IL2 gene expression in CD4+ T lymphocytesBlood, 2006